The ReActiv8 neurostimulation system allows the body to regain control of the multifidus, providing functional lumbar stability and reducing pain.
The ReActiv8 Implantable Neurostimulation System includes an implantable pulse generator (IPG), two stimulation leads, a magnet, and a wireless remote. The IPG delivers electrical stimulation pulses to certain nerves responsible for activating the lumbar multifudus muscle, the key muscles responsible for stabilizing the lower back.
The multifidus muscle is the key stabilizing muscle in the lower back. A single injury to the back can cause impaired muscle control of the multifidus. This lack of muscle control can decrease the spine’s functional stability, leaving the spine susceptible to further injury and overloading. Restoring the neuromuscular control of the multifidus muscle can stabilize the spine, thereby increasing function and decreasing pain.
ReActiv8 is a restorative treatment that focuses on improving function for patients by addressing the underlying cause of instability and pain in the low back. The therapy is designed to help patients who have not responded to other methods of treatment, like medication and physical therapy.
A doctor implants the ReActiv8 IPG in the patient’s lower back and a stimulation lead is placed on the lumbar multifudus muscle on the left and right side of the patient’s spine. The IPG delivers electrical stimulation pulses to the nerves that activate the lumbar multifudus muscle, which can lead to improvement of chronic lower back pain. Using the wireless remote, the patient is able to start, pause, or stop a session of electrical stimulation
The ReActiv8 Implantable Neurostimulation System can decrease chronic lower back pain in patients that have weakness of the lumbar multifudus muscle. In a clinical study, the majority of patients that had the ReActiv8 Implantable Neurostimulation System demonstrated significant improvement in pain symptoms after 120 days as compared to patients who had a device in which sub-optimal stimulation was provided.
ReActiv8 clinical studies show that eight out of 10 patients reported substantial improvements in pain and/or function. Patients experience progressive, long-term improvements in pain and function over time, demonstrating a durable, consistent, and restorative result.
The therapy is not only NICE-approved (National Institute for Health and Care Excellence) but funded by the NHS and readily available on the NHS framework, which means that patients around the country can benefit from ReActiv8.
For more details patients wishing to be considered for the ReActiv8 system can contact ukinfo@mainstaymedical.com. You will be sent a qualifying questionnaire to see if you are eligible and you’ll be able to discuss the therapy further with a ReActiv8 specialist and find out how to gain access to it.
For more information on this pain relieving technique head to Mainstay Medical.
Source: Mainstay Medical Bristol Post FDA
BACK PAIN BLOG UK... 